MaxCyte Statistics
NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
1.37+0.09 (+7.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MaxCyte by the numbers
MaxCyte has a market capitalization of $141.5 million based on 103.25M shares outstanding. With trailing EPS of $-0.26, MaxCyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.2% above its 50-day average and 27.0% above its 200-day average.
Average daily trading volume is 1.04M shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MXCT valuation vs. peer median
| Metric | MXCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $141.45M | $606.82M | -77% |
| Avg. volume | 1.04M | 1.01M | +3% |
Peer median across 8 companies: ONMD, BIAF, ISPC, NRC, OABI, ABSI, ICLR, CRL.
Valuation
- Market cap
- $141.45M
- Price / sales (latest FY)
- 4.28
- EPS (TTM)
- $-0.26
- Shares outstanding
- 103.25M
Price and trading
- Previous close
- 1.28
- Open
- 1.29
- Day range
- 1.27 – 1.42
- 52-week range
- 0.643 – 1.80
- 52-week change
- -17.96%
- Beta
- —
- Volume
- 1.11M
- Average volume
- 1.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 141.45M
- Forward Pe
- -5.96
- Eps
- -0.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.80
- Week52 Low
- 0.64
- Avg Volume
- 1.04M
- Shares Outstanding
- 103.25M
- Ma50
- 1.25
- Ma200
- 1.08
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -23.89%
- Pct From52w Low
- 113.06%